TREATMENT OF RECURRENT PEDIATRIC MYELODYSPLASTIC SYNDROME POST
HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Franziska Wachter
, - Yana Pikman,
- Jacob Bledsoe,
- Malika Kapadia,
- Susanne Baumeister,
- Jared Rowe,
- Akiko Shimamura,
- Andrew E. Place,
- Susan Prockop,
- Jennifer Whangbo,
- Leslie Lehmann,
- John Horan,
- Jessica Pollard
Franziska Wachter
Dana-Farber Cancer Institute Department of Pediatric Oncology
Corresponding Author:franziska_wachter@dfci.harvard.edu
Author ProfileYana Pikman
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileJacob Bledsoe
Boston Children's Hospital Department of Pathology
Author ProfileMalika Kapadia
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileSusanne Baumeister
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileJared Rowe
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileAkiko Shimamura
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileAndrew E. Place
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileSusan Prockop
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileJennifer Whangbo
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileLeslie Lehmann
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileJohn Horan
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author ProfileJessica Pollard
Dana-Farber Cancer Institute Department of Pediatric Oncology
Author Profile15 Oct 2023Submitted to Clinical Case Reports 17 Oct 2023Submission Checks Completed
17 Oct 2023Assigned to Editor
17 Oct 2023Reviewer(s) Assigned
23 Oct 2023Review(s) Completed, Editorial Evaluation Pending
24 Oct 2023Editorial Decision: Revise Minor
26 Oct 20231st Revision Received
27 Oct 2023Submission Checks Completed
27 Oct 2023Assigned to Editor
27 Oct 2023Review(s) Completed, Editorial Evaluation Pending
01 Nov 2023Editorial Decision: Accept
